OLO (NYSE:OLO) vs. Phreesia (NYSE:PHR) Head to Head Survey

Phreesia (NYSE:PHR) and OLO (NYSE:OLO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Profitability

This table compares Phreesia and OLO’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	-20.43%	-32.78%	-22.37%
OLO	-5.89%	0.34%	0.30%

Insider and Institutional Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 93.4% of OLO shares are held by institutional investors. 5.8% of Phreesia shares are held by company insiders. Comparatively, 39.3% of OLO shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Phreesia has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, OLO has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for Phreesia and OLO, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	0	0	13	0	3.00
OLO	0	1	2	0	2.67

Phreesia currently has a consensus target price of $31.15, suggesting a potential upside of 7.45%. OLO has a consensus target price of $8.67, suggesting a potential upside of 16.57%. Given OLO’s higher probable upside, analysts clearly believe OLO is more favorable than Phreesia.

Earnings & Valuation

This table compares Phreesia and OLO”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$356.30 million	4.73	-$136.88 million	($1.47)	-19.72
OLO	$228.29 million	5.33	-$58.29 million	($0.10)	-74.34

OLO has lower revenue, but higher earnings than Phreesia. OLO is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Summary

OLO beats Phreesia on 10 of the 14 factors compared between the two stocks.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About OLO

Olo, Inc. engages in the provision of cloud-based, on-demand commerce platform for multi-location restaurant brands. It enables digital ordering and delivery. The company was founded in 2005 and is headquartered in New York, NY.